Salvianolic acid A promotes the acceleration of neovascularization in the ischemic rat myocardium and the functions of endothelial progenitor cells

Journal of Ethnopharmacology

Volumn 151, Issue 1, 2014, Pages 218-227

  Li, Yu Juan ^a   Duan, Chang Ling ^b   Liu, Jian Xun ^b  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^b XIYUAN HOSPITAL   (China)

Author keywords

Coronary disease; Endothelial progenitor cells; Myocardial ischemia; Salvianolic acid A

Indexed keywords

ANTIOXIDANT; GELATINASE B; HERBACEOUS AGENT; SALVIANOLIC ACID A; SODIUM CHLORIDE; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CELL MIGRATION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DRUG POTENCY; ENDOTHELIAL PROGENITOR CELL; EXPERIMENTAL MYOCARDIAL ISCHEMIA; HEART INFARCTION SIZE; IMMUNOHISTOLOGY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PROTEIN EXPRESSION; RAT; SALVIA MILTIORRHIZA;

RATTUS; SALVIA MILTIORRHIZA;

CORONARY DISEASE; ENDOTHELIAL PROGENITOR CELLS; MYOCARDIAL ISCHEMIA; SALVIANOLIC ACID A;

ANIMALS; CAFFEIC ACIDS; CELL MIGRATION ASSAYS; CELLS, CULTURED; CORONARY VESSELS; CYTOKINES; ENDOTHELIAL CELLS; LACTATES; MALE; MOLECULAR STRUCTURE; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; SPLEEN; STEM CELLS;

EID: 84891489863     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2013.10.019     Document Type: Article

References (39)

1. A.T. Askari, S. Unzek, Z.B. Popovic, C.K. Goldman, F. Forudi, M. Kiedrowski, A. Rovner, S.G. Ellis, J.D. Thomas, P.E. DiCorleto, E.J. Topol, and M.S. Penn Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy Lancet 362 2003 697 703
2. G. Bergers, R. Brekken, G. McMahon, T.H. Vu, T. Itoh, K. Tamaki, K. Tanzawa, P. Thorpe, S. Itohara, Z. Werb, and D. Hanahan Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis Nat. Cell Biol. 2 2000 737 744
3. S. Bernardi, G.M. Severini, G. Zauli, and P. Secchiero Cell-based therapies for diabetic complications Exp. Diabetes Res. 2012 2012 872504
4. P. Carmeliet, and D. Collen Molecular basis of angiogenesis: role of VEGF and VE-cadherin Ann. N. Y. Acad. Sci. 902 2000 249 262
5. T.O. Cheng DanShen: a versatile Chinese herbal drug for the treatment of coronary heart disease Int. J. Cardiol. 113 2006 437 438
6. C.V. Desouza Does drug therapy reverse endothelial progenitor cell dysfunction in diabetes? J. Diabetes Complications 27 2013 519 525
7. S.J. Duthie Berry phytochemicals, genomic stability and cancer: evidence for chemoprotection at several stages in the carcinogenic process Mol. Nutr. Food Res. 51 2007 665 674
8. M. Eguchi, H. Masuda, and T. Asahara Endothelial progenitor cells for postnatal vasculogenesis Clin. Exp. Nephrol. 11 2007 18 25
9. R. Engerman, J.M. Bloodworth Jr., and S. Nelson Relationship of microvascular disease in diabetes to metabolic control Diabetes 26 1977 760 769
10. G.P. Fadini, D. Losordo, and S. Dimmeler Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use Circ. Res. 110 2012 624 637
11. H. Fan, L. Yang, F. Fu, H. Xu, Q. Meng, H. Zhu, L. Teng, M. Yang, L. Zhang, Z. Zhang, and K. Liu Cardioprotective effects of salvianolic acid A on myocardial ischemia-reperfusion injury in vivo and in vitro Evid. Based Complement. Alternative Med. 2012 2012 1 9
12. N. Ferrara, and R.S. Kerbel Angiogenesis as a therapeutic target Nature 438 2005 967 974
13. L.G. Futterman, and L. Lemberg VEGF and TMR: myocardial revascularization in the next millennium Am. J. Crit. Care 8 1999 349 353
14. J.H. Ho, and C.Y. Hong Salvianolic acids: small compounds with multiple mechanisms for cardiovascular protection J. Biomed. Sci. 18 2011 1 5
15. X. Ji, B.K. Tan, Y.C. Zhu, W. Linz, and Y.Z. Zhu Comparison of cardioprotective effects using ramipril and DanShen for the treatment of acute myocardial infarction in rats Life Sci. 73 2003 1413 1426
16. B. Jiang, D. Li, Y. Deng, F. Teng, J. Chen, S. Xue, X. Kong, C. Luo, X. Shen, H. Jiang, F. Xu, W. Yang, J. Yin, Y. Wang, H. Chen, W. Wu, X. Liu, and D.A. Guo Salvianolic acid A, a novel matrix metalloproteinase-9 inhibitor, prevents cardiac remodeling in spontaneously hypertensive rats PLoS One 8 2013 e59621
17. R. Kakkar, and R.T. Lee Intramyocardial fibroblast myocyte communication Circ. Res. 106 2010 47 57
18. H. Kamihata, H. Matsubara, T. Nishiue, S. Fujiyama, Y. Tsutsumi, R. Ozono, H. Masaki, Y. Mori, O. Iba, E. Tateishi, A. Kosaki, S. Shintani, T. Murohara, T. Imaizumi, and T. Iwasaka Implantation of bone marrow mononuclear cells into ischemic myocardium enhance collateral perfusion and regional function via side supply of angioblasts, antigenic ligands, and cytokines Circulation 104 2001 1046 1052
19. K.J. Lavine, and D.M. Ornitz Rebuilding the coronary vasculature: Hedgehog as a new candidate for pharmacologic revascularization Trends Cardiovasc. Med. 17 2007 77 83
20. Y.J. Li, CL Duan, J.X. Liu, and Y.G. Xu Pro-angiogenic actions of salvianolic acids on in vitro cultured endothelial progenitor cells and chick embryo chorioallantoic membrane model J. Ethnopharmacol. 131 2010 562 566
21. L. Lian-Niang, T. Rui, and C. Wei-Ming Salvianolic acid A, a new depside from roots of Salvia miltiorrhiza Planta Med. 50 1984 227 228
22. D. Lyden, K. Hattori, S. Dias, C. Costa, P. Blaikie, L. Butros, A. Chadburn, B. Heissig, W. Marks, L. Witte, Y. Wu, D. Hicklin, Z. Zhu, N.R. Hackett, R.G. Crystal, M.A. Moore, K.A. Hajjar, K. Manova, R. Benezra, and S Rafii Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth Nat. Med. 7 2001 1194 1201
23. C.J. Morabito, R.W. Dettman, J. Kattan, J.M. Collier, and J. Bristow Positive and negative regulation of epicardial-mesenchymal transformation during avian heart development Dev. Biol. 234 2001 204 215
24. K. Ogawa, H. Yaoita, M. Okamoto, K. Ikeda, T. Shichishima, H. Ohto, K. Maehara, and Y. Maruyama Transient improvement of left ventricular function after peripheral blood stem cell transplantation in a patient with myelodysplastic syndrome and dilated cardiomyopathy Circ. J. 68 2004 958 960
25. T.R. Payne, H. Oshima, M. Okada, N. Momoi, K. Tobita, B.B. Keller, H. Peng, and J. Huard A relationship between vascular endothelial growth factor, angiogenesis, and cardiac repair after muscle stem cell transplantation into ischemic hearts J. Am. Coll. Cardiol. 50 2007 1677 1684
26. M.S. Pepper, R. Montesano, S.J. Mandriota, L. Orci, and J.D. Vassalli Angiogenesis: a paradigm for balanced extracellular proteolysis during cell migration and morphogenesis Enzyme Protein 49 1996 138 162
27. G.S. Pinkus, C.L. Etheridge, and E.M. O'Connor Are keratin proteins a better tumor marker than epithelial membrane antigen? A comparative immunohistochemical study of various paraffin-embedded neoplasms using monoclonal and polyclonal antibodies Am. J. Clin. Pathol. 85 1986 269 277
28. R. Roy, J. Yang, and M.A. Moses Matrix metalloproteinase as novel biomarkers and potential therapeutic targets in human cancer J. Clin. Oncol. 27 2009 5287 5297
29. A. Scalbert, C. Manach, C. Morand, C. Rémésy, and L. Jiménez Dietary polyphenols and the prevention of diseases Crit. Rev. Food Sci. Nutr. 45 2005 287 306
30. V. Schächinger, S. Erbs, A. Elsässer, W. Haberbosch, R. Hambrecht, H. Hölschermann, J. Yu, R. Corti, D.G. Mathey, C.W. Ham, T. Süselbeck, B. Assmus, T. Tonn, S. Dimmeler, A.M. Zeiher, and REPAIR-AMI Investigators Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction N. Engl. J. Med. 355 2006 1210 1221
31. N.R. Sodha, L.M. Chu, M. Boodhwani, and F.W. Sellke Pharmacotherapy for end-stage coronary artery disease Expert Opin. Pharmacother. 11 2010 207 213
32. Y.P. Song, L.S. Kong, and J. Wu Comparison of the effect of salvianolic acid A and B on acute myocardial ischemia of rats Chin. J. Inf. TCM 14 2007 36 38
33. I. Spyridopoulos, E. Brogi, M. Kearney, A.B. Sullivan, C. Cetrulo, J.M. Isner, and D.W. Losordo Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-alpha: balance between growth and death signals J. Mol. Cell Cardiol. 29 1997 1321 1330
34. N. Svorkdal Treatment of inoperable coronary disease and refractory angina: spinal stimulators, epidurals, gene therapy, transmyocardial laser, and counterpulsation Semin. Cardiothorac. Vasc. Anesth. 8 2004 43 58
35. M. Vasa, S. Fichtlscherer, A. Aicher, K. Adler, C. Urbich, H. Martin, A.M. Zeiher, and S. Dimmeler Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease Circ. Res. 89 2001 El E7
36. S.B. Wang, S. Tian, F. Yang, H.G. Yang, X.Y. Yang, and G.H. Du Cardioprotective effect of salvianolic acid A on isoproterenol-induced myocardial infarction in rats Eur. J. Pharmacol. 615 2009 125 132
37. L.L. Yang, D.Y. Li, Y.B. Zhang, M.Y. Zhu, D. Chen, and T.D. Xu Salvianolic acid A inhibits angiotensin II-induced proliferation of human umbilical vein endothelial cells by attenuating the production of ROS Acta Pharmacol. Sin. 33 2012 41 48
38. P.P. Young, D.E. Vaughan, and A.K. Hatzopoulos Biologic properties of endothelial progenitor cells and their potential for cell therapy Prog. Cardiovasc. Dis. 49 2007 421 429
39. Y.Q. Zhang, Y. Tang, A.L. Wu, and H.B. Zhu Salvianolic acid A displays cardioprotective effects in in vitro models of heart hypoxia/reoxygenation injury J. Asian Nat. Prod. Res. 12 2010 899 915